This protocol is judged by an institutional review board, an unbiased team that evaluations any clinical trials involving people. If a study requires a Routine I drug, when the board approves the protocol as moral, the researchers really have to submit an application for an investigational new drug (IND) quantity within the FDA.Using the doses pac